ReNeuron Group plc (LON:RENE – Get Free Report) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 3.38 ($0.04) and traded as high as GBX 3.50 ($0.04). ReNeuron Group shares last traded at GBX 3.38 ($0.04), with a volume of 177,373 shares changing hands.
ReNeuron Group Price Performance
The stock’s fifty day moving average price is GBX 3.38 and its two-hundred day moving average price is GBX 4.19. The firm has a market capitalization of £1.93 million, a price-to-earnings ratio of -37.50 and a beta of 0.69. The company has a current ratio of 1.51, a quick ratio of 2.02 and a debt-to-equity ratio of 14.25.
ReNeuron Group Company Profile
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease.
Featured Articles
- Five stocks we like better than ReNeuron Group
- What are earnings reports?
- MarketBeat Week in Review – 4/15 – 4/19
- Earnings Per Share Calculator: How to Calculate EPS
- Comprehensive Analysis of PayPal Stock
- There Are Different Types of Stock To Invest In
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for ReNeuron Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReNeuron Group and related companies with MarketBeat.com's FREE daily email newsletter.
